The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Measles Elimination in the United States
Abstract
In 1962, immediately preceding the licensure of the first measles vaccines in the United States, when measles was a nearly universal disease, Alexander Langmuir described the medical importance of measles to the country and put forth the challenge of measles eradication [1]. Although most patients recovered without permanent sequelae, the high number of cases each year made measles a significant cause of serious morbidity and mortality Langmuir showed that >90% of Americans were infected with the measles virus by age 15 years [1]. This equated to roughly 1 birth cohort (4 million people) infected with measles each year. Not all cases were reported to the public health system; from 1956 to 1960, an average of 542,000 cases were reported annually.By the late 1950s, even before the introduction of measles vaccine, measles-related deaths and case fatality rates in the United States had decreased markedly, presumably as a result of improvement in health care and nutrition. From 1956 to 1960, an average of 450 measles-related deaths were reported each year (∼1 death/ 1000 reported cases), compared with an average of 5300 measles-related deaths during 1912–1916 (26 deaths/ 1000 reported cases) [2]. Nevertheless, in the late 1950s, serious complications due to measles remained frequent and costly. As a result of measles virus infections, an average of 150,000 patients had respiratory complications and 4000 patients had encephalitis each year; the latter was associated with a high risk of neurological sequelae and death. These complications and others resulted in an estimated 48,000 persons with measles being hospitalized every year [3]. In 1966, 3 years after licensure of the first measles vaccines, Sencer et al. [4] announced the first of 3 efforts to terminate indigenous measles transmission in the United States. Subsequent measles-elimination goals were announced in 1978 and in 1993. The fundamental strategy for all 3 elimination efforts consisted of achieving high vaccination coverage among preschool- and school-aged children, careful surveillance of cases, and rigorous outbreak control [4–6]. Although the first 2 elimination efforts did not achieve elimination, they resulted in a substantial reduction in measles incidence: An average of 1.3 cases per 100,000 population was reported during 1982–1988, compared with an average of 313 cases per 100,000 during 1956–1960 (figure 1). Nevertheless, a resurgence of measles occurred during 1989–1991, again demonstrating the serious medical burden of the disease. More than 55,000 cases, 123 deaths, and 11,000 hospitalizations were reported [7]. Two major causes of this epidemic were vaccine failure among a small percentage of school-aged children who had received 1 dose of measles vaccine and low measles vaccine coverage among preschool-aged children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Cited by
Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases
Omer, S. B., Salmon, D. A., Orenstein, W. A., deHart, M. P., & Halsey, N. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0806477 · Cited by 997
Roush, S. W. (2007) · JAMA · doi:10.1001/jama.298.18.2155 · Cited by 633
Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States
Lo, N. C., & Hotez, P. J. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.1695 · Cited by 355
Simons, E., Ferrari, M., Fricks, J., Wannemuehler, K., Anand, A., Burton, A., & Strebel, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60522-4 · Cited by 312
Metadata
- Authors
- Wharton, M. E.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 189
- Issue
- Supplement_1
- Pages
- S1-S3
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2163575699
- Cited by
- 159
- References
- 1
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Measles Elimination in the United States. https://app.cochat.ai/papers/10.1086/377693
- The paper
- Wharton, M. E. (2004). Measles Elimination in the United States. The Journal of Infectious Diseases. https://doi.org/10.1086/377693
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.